Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

AngioScore completes its $12mm Series F round

Executive Summary

AngioScore Inc. (endovascular devices) has raised $12mm through what is believed to be its Series F venture round. New institutional investor Saints Capital led (and contributes a board member) and was joined by current backers, including Psilos Group Managers, Telegraph Hill Partners, QuestMark Partners, Pelion Venture Partners, California Technology Ventures, and Innomed Ventures, as well as 15 other undisclosed investors. Funds will be used to continue developing a 100mm AngioSculpt scoring balloon catheter for peripheral artery disease, a drug-coated AngioSculpt scoring balloon catheter, and an AngioSculpt scoring balloon for valvuloplasty and use in transaortic valve implantation procedures.

Deal Industry
  • Medical Devices
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies